Literature DB >> 15355555

Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women.

Susan P Moffett1, Joseph M Zmuda, Jane A Cauley, Katie L Stone, Michael C Nevitt, Kristine E Ensrud, Teresa A Hillier, Marc C Hochberg, Geoff Joslyn, Phillip Morin, Steven R Cummings.   

Abstract

UNLABELLED: We analyzed the association between the IL-6 G-174C polymorphism and osteoporosis phenotypes in 3376 older women. Women with the C/C genotype had a significantly slower rate of decline in hip BMD and a 33% lower risk of wrist fracture than women with the G/G genotype. Variation at the IL-6 locus may contribute to the genetic susceptibility to bone fragility.
INTRODUCTION: Interleukin 6 (IL-6) promotes osteoclast formation and bone resorption. The C allele of the G-174C polymorphism in the IL-6 promoter region has been related to lower gene transcription and plasma IL-6 levels.
MATERIALS AND METHODS: In this study, we evaluated the relationship between the IL-6 G-174C polymorphism and BMD, the rate of decline in BMD, and the risk of fracture in 3376 women 65 years of age and older participating in the Study of Osteoporotic Fractures. BMD was measured at the distal and proximal radius using single photon absorptiometry and at the hip using DXA. Hip BMD was measured again an average of 3.5 years later. Incident fractures over an average of 10.8 years of follow-up were confirmed by physician adjudication of radiology reports.
RESULTS: Distal and proximal radius BMD was lowest among women with the G/G genotype, intermediate in the heterozygotes, and highest in women with the C/C genotype (p = 0.016 and p = 0.049, respectively), although the differences between the genotypes were small. While there were no differences by genotype with initial hip BMD, women with the C/C genotype experienced a slower rate of decline in total hip and femoral neck BMD compared with women with the G/G genotype (p = 0.004 and p = 0.029, respectively). Women with the C/C genotype also had 33% lower risk of wrist fracture compared with women with the G/G genotype, independent of age, body mass index, estrogen use, and study center (RR, 0.67; 95% CI, 0.45, 1.00; p = 0.048), whereas heterozygous women had a more intermediate risk (RR, 0.85; 95% CI, 0.65, 1.12; p = 0.256). No association was found between genotype and risk of hip or all non-spine fractures.
CONCLUSIONS: These results suggest that the IL-6 G-174C promoter polymorphism may be a genetic marker for bone loss and wrist fracture among older women.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355555     DOI: 10.1359/JBMR.040707

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

Review 1.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

Review 2.  Interleukin-6 in aging and chronic disease: a magnificent pathway.

Authors:  Marcello Maggio; Jack M Guralnik; Dan L Longo; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-06       Impact factor: 6.053

Review 3.  The genetics of bone loss: challenges and prospects.

Authors:  Braxton D Mitchell; Laura M Yerges-Armstrong
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

4.  Bone mineral density-affecting genes in Africans.

Authors:  Gordon Gong; Gleb Haynatzki; Vera Haynatzka; Ryan Howell; Sade Kosoko-Lasaki; Yun-Xin Fu; Fei Yu; John C Gallagher; M Roy Wilson
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

Review 5.  Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty.

Authors:  Luigi Ferrucci; Elisa Fabbri
Journal:  Nat Rev Cardiol       Date:  2018-09       Impact factor: 32.419

Review 6.  Association between interleukin-6 gene polymorphisms and bone mineral density: a meta-analysis.

Authors:  Zhao Wang; Yonghong Yang; Minjuan He; Ran Wang; Juming Ma; Yimin Zhang; Lingyun Zhao; Ke Yu
Journal:  Genet Test Mol Biomarkers       Date:  2013-09-21

7.  Association tests of interleukin-6 (IL-6) and type II tumor necrosis factor receptor (TNFR2) genes with bone mineral density in Caucasians using a re-sampling approach.

Authors:  Peng Xiao; Peng-Yuan Liu; Yan Lu; Yan-Fang Guo; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

8.  Genetic variation in candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures.

Authors:  Gregory J Tranah; Brent C Taylor; Li-Yung Lui; Joseph M Zmuda; Jane A Cauley; Kristine E Ensrud; Teresa A Hillier; Marc C Hochberg; Jia Li; Brian K Rhees; Henry A Erlich; Mark D Sternlicht; Gary Peltz; Steven R Cummings
Journal:  Calcif Tissue Int       Date:  2008-09-12       Impact factor: 4.333

9.  Effect of interleukin-6 polymorphism on fracture risk.

Authors:  Chuangli Wang; Jianfei Ge; Shanjun Ni
Journal:  Int J Clin Exp Med       Date:  2015-06-15

10.  Association of IL-6 G-174C polymorphism with bone mineral density.

Authors:  Yuanyuan Ni; Hua Li; Yang Zhang; Hao Zhang; Yongchu Pan; Junqing Ma; Lin Wang
Journal:  J Bone Miner Metab       Date:  2013-06-13       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.